SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-022264
Filing Date
2023-05-15
Accepted
2023-05-15 16:44:25
Documents
16
Period of Report
2023-05-15
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K tern-20230515.htm   iXBRL 8-K 64450
2 EX-1.1 tern-ex1_1.htm EX-1.1 442600
3 EX-5.1 tern-ex5_1.htm EX-5.1 18579
4 GRAPHIC img60210087_0.jpg GRAPHIC 13699
5 GRAPHIC img60210087_1.jpg GRAPHIC 121921
  Complete submission text file 0000950170-23-022264.txt   902846

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT tern-20230515_lab.xml EX-101.LAB 14572
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT tern-20230515.xsd EX-101.SCH 2478
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT tern-20230515_pre.xml EX-101.PRE 10683
10 EXTRACTED XBRL INSTANCE DOCUMENT tern-20230515_htm.xml XML 5119
Mailing Address 1065 EAST HILLSDALE BLVD., SUITE 100 FOSTER CITY CA 94404
Business Address 1065 EAST HILLSDALE BLVD., SUITE 100 FOSTER CITY CA 94404 650-525-5535 EXT.101
Terns Pharmaceuticals, Inc. (Filer) CIK: 0001831363 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39926 | Film No.: 23923547
SIC: 2834 Pharmaceutical Preparations